Infection after acute ischemic stroke: A manifestation of brain-induced immunodepression

Stroke

Volumn 38, Issue 3, 2007, Pages 1097-1103

  Chamorro, Ángel ^a,c   Urra, Xabier ^a   Planas, Anna M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Acute stroke; Complications; Immunology; Infectious disease; Pathogenesis

Indexed keywords

ANTIBIOTIC AGENT; CATECHOLAMINE; CHEMOKINE; CORTICOTROPIN; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; LEVOFLOXACIN; NITRIC OXIDE; PROPRANOLOL; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADRENERGIC SYSTEM; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFECTION; BRAIN ISCHEMIA; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE SEVERITY; EXPERIMENTAL MOUSE; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPETENCE; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MORTALITY; NERVE TRACT; NEUROENDOCRINE SYSTEM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; STROKE PATIENT; SYMPTOMATOLOGY; BRAIN; CEREBROVASCULAR ACCIDENT; COMMUNICABLE DISEASE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PATHOLOGY; REVIEW; TIME;

BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMMUNICABLE DISEASES; HUMANS; IMMUNOSUPPRESSION; TIME FACTORS;

EID: 33947515643     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000258346.68966.9d     Document Type: Article

References (100)

1. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke. 2006;37:291-293.
2. Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003;34:671-675.
3. Syrjanen J. Vascular diseases and oral infections. J Clin Periodontol. 1990;17:497-500.
4. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.
5. Hindfelt B, Nilsson O. Brain infarction in young adults with particular reference to pathogenesis. Acta Neurol Scand. 1977;55:145-157.
6. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infraction, and stroke. Clin Infect Dis. 1998;26:719-734.
7. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-2618.
8. Grau AJ, Buggle F, Steichen-Wiehn C, Heindl S, Banerjee T, Seitz R, Winter R, Forsting M, Werle E, Bode C, Nawroth PP, Becher H, Hacke W. Clinical and biochemical analysis in infection-associated stroke. Stroke. 1995;26:1520-1526.
9. Valtonen V, Kuikka A, Syrjanen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J. 1993;14:20-23.
10. Ameriso SF, Wong VL, Quismorio FP Jr, Fisher M. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke. 1991;22:11004-11009.
11. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, Quismorio FP Jr, Weiner JM, Fisher M. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke. 1996;27:2005-2011.
12. Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol. 2005;25:1519-1523.
13. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000;52:595-638.
14. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk HD, Docke WD. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 1998;4:808-813.
15. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 1997;3:678-681.
16. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand. 1987;222:401-408.
17. Vernino S, Brown RD Jr, Sejvar JJ, Sicks JD, Petty GW, O'Fallon WM. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828-1832.
18. Dromerick A, Reding M. Medical and neurological complications during inpatient stroke rehabilitation. Stroke. 1994;25:358-361.
19. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990;53:824-829.
20. Kalra L, Yu G, Wilson K, Roots P. Medical complications during stroke rehabilitation. Stroke. 1995;26:990-994.
21. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke. 1996;27:415-420.
22. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, Faught RE Jr, Haley EC Jr. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke. 1998;29:447-453.
23. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G. Medical complications after stroke: a multicenter study. Stroke. 2000;31:1223-1229.
24. Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W. Fever and infection early after ischemic stroke. J. Neurol. Sci. 1999;171:115-120.
25. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, Rother J, Buecker-Nott HJ, Berger K; German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004;164:1761-1768.
26. Hamidon BB, Raymond AA, Norlinah MI, Jefferelli SB. The predictors of early infection after an acute ischaemic stroke. Singapore Med J. 2003;44:344-346.
27. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975-981.
28. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer ML, Busse O, Haberl RL, Diener HC; German Stroke Date Bank Collaborators. Complications following acute ischemic stroke. Eur Neurol. 2002;48:133-140.
29. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F, Planas AM, Mensa J, Chamorro A. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke. 2006;37:461-465.
30. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620-625.
31. Smithard DG, O'Neill PA, Parks C, Morris J. Complication and outcome after acute stroke: does dysphagia matter? Stroke. 1996;7:1200-1204.
32. Marlene AH, Kathleen LD, Michael JR. Aspiration and relative risk of medical complications following stroke. Arch Neurol. 1994;51:1051-1053.
33. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation Stroke. 2001;32:523-529.
34. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke. 1998;29:529-534.
35. Nemoto EM, Frankel HM. Cerebral oxygenation and metabolism during progressive hyperthermia. Am J Physiol. 1970;219:1784-1788.
36. Busto R, Globus MY, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke. 1989;20:904-910.
37. Martinez MA, Pena JM, Fernandez A, Jimenez M, Juarez S, Madero R, Vazquez JJ. Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-α. Crit Care Med. 1999;27:1303-1308.
38. Conway EM, Bach R, Rosenberg RD, Konigsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res. 1989;53:231-241.
39. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 1989;73:159-165.
40. Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke. 2001;32:413-417.
41. Castillo J, Martinez F, Leira R, Prieto JM, Lema M, Noya M. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc Dis. 1994;4:66-71.
42. Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422-425.
43. Aslanyan CJ, Weir CJ, Dienerc HC, Kaste M, Lees KR; for the GAIN International Steering Committee and Investigator. Pneumonia and urinary tract infection after acute ischaemic stroke:a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49-53.
44. Dziewas R, Ritter M, Schilling M, Konrad C, Oelenberg S, Nabavi DG, Stogbauer F, Ringelstein EB, Ludemann P. Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry. 2004;75:852-856.
45. Kwan J, Roberts HC; Englyst N. Do we really understand the pathophysiology and clinical impact of poststroke infection? Stroke. 2006;37:1656.
46. Basi S, Marrie TJ, Huang JQ, Sumit R, Majumdar S. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcome. Am J Med. 2004;117:305-311.
47. Chamorro A, Vargas M, Mensa J. Do we really understand the pathophysiology and clinical impact of poststroke infection? Stroke. 2006;37:1657.
48. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, Cervera A, Planas AM, Mensa J. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke. 2005;36:1495-1500.
49. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989;69:1-32.
50. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. PhysiolRev. 1999;79:1-71.
51. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
52. Buller KM. Circumventricular organs: gateways to the brain: role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis. Clin Exp Pharmacol Phsyiol. 2001;28:581-589.
53. Rivier C, Plotsky PM. Mediation by corticotrophin-releasing factor (CRF) of adenohypophysisal hormone secretion. Annu Rev Physiol. 1986;48:475-494.
54. Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today. 1997;18:418-424.
55. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002;195:603-616.
56. Tuosto L, Cundari E, Montani MS, Piccolella E. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol. 1994;24:1061-1065.
57. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652-654.
58. Sawchenko PE, Brown ER, Chan RKW, Ericsson A, Li HY, Roland BL, Kovacs KJ. The paraventricular nucleus of the hypothalamus and functional neuroanatomy of viscereomotor responses to stress. Prog Brain Res. 1996;107:201-222.
59. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9:125-134.
60. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002;195:781-788.
61. Berkenbosh F, de Goeij DE, Rey AD, Besedovsky HO. Neuroendocrine, sympathetic and metabolic responses induced by interleukin 1. Neuroendocrinology. 1989;50:570-576.
62. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-1252.
63. Kin NW, Sanders VM. It takes nerves to tell T and B cells what to do. J Leukoc Biol. 2006;79:1-12.
64. Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JW. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci. 1995;88:533-542.
65. Eisenhofer G, Rundquist B, Aneman A, Friberg P, Dakak N, Kopin IJ, Jacobs MC, Lenders JW. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab. 1995;80:3009-3017.
66. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh T-T, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders J. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998;83:2175-2185.
67. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Therap. 2003;305:800-811.
68. Felten DL. Neural influence on immune responses: underlying suppositions and basic principles of neural-immune signaling. Prog Brain Res. 2000;122:381-389.
69. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997;158:4200-4210.
70. Kohm AP, Sanders VM. Norpeinephrine and β 2-adrenergic receptor stimulation regulates CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53:487-525.
71. Woiciechowsky C, Schöning B, Lanksch WR, Volk HD, Docke HD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med. 1999;77:769-780.
72. Tang Y, Shankar R, Gamelli R, Jones S. Dynamic norepinephrine alterations in bone marrow: Evidence of functional innervation. J Neuroimmunol. 1999;96:182-189.
73. Fink GD, Fisher JW. Stimulation of erythropoiesis by beta adrenergic agonists. I. Characterization of activity in polycythemic mice. J Pharmacol Exp Ther. 1977;202:192-198.
74. Maestroni GJ, Conti A. Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol. 1994;22:313-320.
75. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke: relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke. 1994;25:1105-1108.
76. Olsson T, Marklund N, Gustafson Y, Nasman B. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke. 1992;23:1573-1576.
77. Johansson A, Ahren B, Nasman B, Carlstrom K, Olsson T. Cortisol axis abnormalities early after stroke - relationships to cytokines and leptin. J Intern Med. 2000;247:179-187.
78. Marklund N, Peltonen M, Nilsson TK, Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med. 2004;256:15-21.
79. Schwarz S, Schwab S, Klinga K, Maser-Gluth C, Bettendorf M. Neuroendocrine changes in patients with acute space occupying ischemic stroke. J Neurol Neurosurg Psychiatry. 2003;74:725-727.
80. Slowik A, Turaj W, Pankiewicz J, Dziedzic T, Szermer P, Szczudlik A. Hypercortisolemia in acute stroke is related to the inflammatory response. J Neurol Sci. 2002;196:27-32.
81. Olsson T. Urinary free cortisol excretion shortly after ischaemic stroke. J Intern Med. 1990;228:177-181.
82. Myers MG, Norris JW, Hachninski VC, Sole MJ. Plasma norepinephrine in stroke. Stroke. 1981;12:200-204.
83. Smith KE, Hachinski VC, Gibson CJ, Ciriello J. Changes in plasma catecholamine levels after insula damage in experimental stroke. Brain Res. 1986;375:182-185.
84. Robinson TG, James M, Youde J, Panerai R, Potter J. Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke. 1997;28:1671-1676.
85. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725-736.
86. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176:6523-6531.
87. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26:654-665.
88. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 2004;35:2576-2581.
89. Czlonkowska A, Cyrta B, Korlak J. Immunological observations on patients with acute cerebral vascular disease. J Neurol Sci. 1979;43:455-464.
90. Tarkowski E, Blomstrand C, Tarkowski A. Stroke induced lateralization of delayed-type hypersensitivity in the early and chronic phase of the disease: a prospective study. J Clin Lab Immunol. 1995;6:73-83.
91. Kawaharada M, Urasawa K. Immunological functions and clinical course of elderly patients with cerebrovascular diseases. Nippon Ronen Igakkai Zasshi. 1992;29:652-660.
92. Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D, du Souich P, Kouassi E. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 2002;955:85-97.
93. Meisel C, Prass K, Braun J, Victorov I, Wolf T, Megow D, Halle E, Volk HD, Dirnagl U, Meisel A. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke. 2004;35:2-6.
94. Dirnagl U, Klehmet J, Braun JS, harás H, Meisel C, Ziemssen T, Prass K, Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2006. In press.
95. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM. Interleukin-10, monocytes, and increased risk of infection in ischemic stroke. J Neurol Neurosurg Psichiatry. 2006;77:1279-1281.
96. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology. 2001;103:131-136.
97. O'Farrell AM, Liu Y, Moore KW, Mui AL. IL-10 inhibits macrophage activation and proliferation by distinct signalling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 1998;16:1006-1018.
98. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998;351:950-953.
99. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, Torres F, Planas AM. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007; 252:29-35.
100. Bornstein SR, González-Hernández JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab. 1994;78:225-232.